J. Mark Sloan, MD
Associate Professor
Boston University School of Medicine
Dept of Medicine
Hematology & Medical Oncology

MD, Yale University School of Medicine




My clinical expertise is in clinical hematology, especially lymphoma, leukemia, myeloma, amyloidosis, myelodysplasia and bone marrow transplantation. I also have expertise in the treatment of Jehovah's witnesses


A Phase I Dose-Escalation Study of Carflizomib in Patients with Previously-Treated Systemic Light-Chain (AL) Amyloidosis
12/12/2013 - 12/12/2019 (Co-PI)
PI: Vaishali Sanchorawala, MBBS
Academic Myeloma Consortium


A PhaseLLL, Double-Blind, Randomized, Placebo-Controlled, MultiCenter Clinical trial to Study the Safety, Tolerability, Efficacy, and Immunogenicity of V212 in recipeint of Autologous Hematopoiet
12/06/2010 - 12/31/2014 (PI)
Merck & Company, Inc.



Brentuximab Vedotin with Cyclophosphamide, Doxorubicin, Etoposide, and Prednisone (BV-CHEP) for…
09/19/2018 - 09/18/2021 (PI)
University of North Carolina

Protocol 39039039STM4001
06/29/2016 - 06/29/2019 (PI)
Janssen Pharmaceutica Inc.

Idelalisib for IgM-Associated AL Amyloidosis
12/01/2015 - 12/01/2018 (PI)
Gilead Sciences

CRLF2-signaling in B-cell acute lymphoblastic leukemia
03/14/2016 - 02/28/2017 (PI)
Dana Farber NIH-NCI



Yr Title Project-Sub Proj Pubs
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Pemmaraju N, Lane AA, Sweet KL, Stein AS, Vasu S, Blum W, Rizzieri DA, Wang ES, Duvic M, Sloan JM, Spence S, Shemesh S, Brooks CL, Balser J, Bergstein I, Lancet JE, Kantarjian HM, Konopleva M. Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm. N Engl J Med. 2019 04 25; 380(17):1628-1637. PMID: 31018069.
     
  2. Leiva O, McMahon L, Sloan JM, Lee J, Lerner A. Recognition of hemophagocytic lymphohistiocytosis in sickle cell vaso-occlusive crises is a potentially lifesaving diagnosis. Haematologica. 2019 Apr; 104(4):e167-e169.View Related Profiles. PMID: 30705096.
     
  3. Phull P, Sanchorawala V, Brauneis D, Sloan JM, Siddiqi OK, Quillen K, Sarosiek S. High-dose melphalan and autologous peripheral blood stem cell transplantation in patients with AL amyloidosis and cardiac defibrillators. Bone Marrow Transplant. 2019 Jan 21.View Related Profiles. PMID: 30664726.
     
  4. Gupta VK, Brauneis D, Shelton AC, Quillen K, Sarosiek S, Sloan JM, Sanchorawala V. Induction Therapy with Bortezomib and Dexamethasone and Conditioning with High-Dose Melphalan and Bortezomib Followed by Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis: Long-Term Follow-Up Analysis. Biol Blood Marrow Transplant. 2019 May; 25(5):e169-e173.View Related Profiles. PMID: 30639823.
     
  5. Dennis M, Maoz A, Hughes D, Sanchorawala V, Sloan JM, Sarosiek S. Bortezomib ocular toxicities: Outcomes with ketotifen. Am J Hematol. 2019 Mar; 94(3):E80-E82.View Related Profiles. PMID: 30575098.
     
  6. Angel-Korman A, Stern L, Sarosiek S, Sloan JM, Doros G, Sanchorawala V, Havasi A. Long-term outcome of kidney transplantation in AL amyloidosis. Kidney Int. 2019 Feb; 95(2):405-411.View Related Profiles. PMID: 30580886.
     
  7. Nguyen VP, Landau H, Quillen K, Brauneis D, Shelton AC, Mendelson L, Rahman H, Sloan JM, Sarosiek S, Sanchorawala V. Modified High-Dose Melphalan and Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis. Biol Blood Marrow Transplant. 2018 09; 24(9):1823-1827.View Related Profiles. PMID: 29933072.
     
  8. Sarosiek S, Quillen K, Sloan JM, Brauneis D, Sanchorawala V. Heparin-induced thrombocytopenia and thrombosis during high dose melphalan and autologous stem cell transplantation. Blood. 2018 Aug 16; 132(7):755-757.View Related Profiles. PMID: 29903887.
     
  9. White PS, Phull P, Brauneis D, Sloan JM, Quillen K, Sarosiek S, Sanchorawala V. High-dose melphalan and stem cell transplantation in AL amyloidosis with elevated cardiac biomarkers. Bone Marrow Transplant. 2018 12; 53(12):1593-1595.View Related Profiles. PMID: 29884854.
     
  10. Pudusseri A, Smith I, Sarnacki D, Brauneis D, Shelton A, Sanchorawala V, Sloan JM, Sarosiek S, Quillen K. Evaluation of a new continuous mononuclear cell collection procedure in a single transplant center cohort enriched for AL amyloidosis patients. Transfus Apher Sci. 2018 Jun; 57(3):411-415.View Related Profiles. PMID: 29731423.
     
Showing 10 of 53 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 51 publications over 15 distinct years, with a maximum of 7 publications in 2017

YearPublications
19901
20021
20041
20081
20091
20101
20115
20125
20133
20144
20154
20166
20177
20186
20195
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

AL amyloidosis
Hodgkin Lymphoma
Leukemia
Multiple Myeloma
myelodysplasia
Non-Hodgkin Lymphoma
Thrombosis and IVC filters

Available to Mentor as: (Review Mentor Role Definitions):
  • Advisor
  • Career Mentor
  • Education Mentor
  • Research / Scholarly Mentor
Contact for Mentoring:


820 Harrison Ave
Boston MA 02118
Google Map


Sloan's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department